Study Evaluating Benefit of Using Fibrin Glue in Septorhinoplasty
NCT ID: NCT00713596
Last Updated: 2016-04-18
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
25 participants
INTERVENTIONAL
2008-07-31
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Analysis of Hemostatic Agents Compared to Physiologic Hemostasis
NCT03068728
Efficacy of Seprapack Sinus Dressing Versus No Dressing in the Prevention of Intranasal Adhesions Following Sinus Surgery
NCT00140608
Outcomes of PRF on Septoplasty in Patient With Nasal Septal Deviation
NCT06996106
Septorhinoplasty Post-operative Pain Control With SPG Nerve Block
NCT05667324
Nasal Splint and Endoscopic Nasal Septal Repair Surgery
NCT03575689
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
Septorhinoplasty with postoperative application of nasal taping and an external nasal cast. The tape and cast will be left in place for one week. No tissue glue will be used during the operation, although the nurse and surgical assistant will simulate the preparation and insertion of tissue glue using a syringe containing saline.
Septorhinoplasty
Septorhinoplasty to correct nasal deviation.
Taping after septorhinoplasty.
Simple taping over the nose following nasal surgery.
Cast applied to the nose after nasal surgery
A molded cast will be placed on top of the nose following nasal surgery.
Saline
Approximately 0.5 cc to 2 cc normal saline will be applied after the operation before the nasal taping and casting.
Fibrinogen, tape, and cast
Septorhinoplasty will be performed. At the termination of the procedure, prior to closure, fibrin sealant will be applied by the surgical assistant to the surgical site. Approximately 0.5 cc to 2 cc of tissue sealant will be applied. After closure, tape and cast will be applied and left in place for one week.
Fibrinogen
One time application of 0.5 cc to 2.0 cc of fibrinogen following surgery.
Septorhinoplasty
Septorhinoplasty to correct nasal deviation.
Taping after septorhinoplasty.
Simple taping over the nose following nasal surgery.
Cast applied to the nose after nasal surgery
A molded cast will be placed on top of the nose following nasal surgery.
Fibrinogen and tape
Septorhinoplasty will be performed. At the termination of the procedure, prior to closure, 0.5 cc to 2 cc of tissue sealant will be applied. Nasal tape will be applied after closure.
Fibrinogen
One time application of 0.5 cc to 2.0 cc of fibrinogen following surgery.
Septorhinoplasty
Septorhinoplasty to correct nasal deviation.
Taping after septorhinoplasty.
Simple taping over the nose following nasal surgery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fibrinogen
One time application of 0.5 cc to 2.0 cc of fibrinogen following surgery.
Septorhinoplasty
Septorhinoplasty to correct nasal deviation.
Taping after septorhinoplasty.
Simple taping over the nose following nasal surgery.
Cast applied to the nose after nasal surgery
A molded cast will be placed on top of the nose following nasal surgery.
Saline
Approximately 0.5 cc to 2 cc normal saline will be applied after the operation before the nasal taping and casting.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oren Friedman, M.D.
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06-009614
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.